Categories: News

Eddy Travels Defies Market Trends in Closing �1.1M Euros Pre-Seed Round

Vilnius, Lithuania, April 14, 2020 –(PR.com)– Eddy Travels AI travel assistant has raised an additional 600,000 EUR investment, closing a pre-seed round of 1.1 million euros. The round was led by the Practica Capital VC fund, with participation from Open Circle Capital, Techstars Toronto, and angel investors.

Over 2 million users worldwide have sent voice and text messages to Eddy Travels to find the best travel deals. The digital assistant is available on Facebook Messenger, WhatsApp, Telegram, and other popular chat apps. Eddy Travels is building a unique machine learning technology for natural language processing and personalization.

The new investment will be used for the immediate development of features to help travelers during the coronavirus crisis. After the COVID-19 pandemic, once the travel restrictions are lifted, the funding will be used to expand to new markets.

“The travel industry was severely hit, and it will take some time to recover from COVID-19 impact, we also believe traveler habits might change. Eddy Travels is in a unique position to use this pause and emerge strongly to serve the new needs of travelers and the travel industry with natural language processing and personalization technology. We been with the company already for a year and based on Eddy Travels growth and a plan to use new opportunities we are leading Eddy Travels pre-seed round.” -Donatas Keras, partner at Practica Capital.

Will Cardwell, partner at Open Circle Capital: “Before the crisis, Eddy Travels was able to grow in a few months from 100k users to nearly 2M users. The numbers show that travelers around the world already require advanced yet simple to use solutions to plan travel, and new needs will emerge after the COVID-19 crisis. We believe that additional investment and the founders’ experience will help Eddy Travels to emerge as one of the top travel tech startups.”

Eddy Travels is a travel tech startup founded by Edmundas Balčikonis, Pranas Kiziela and Adomas Baltagalvis in Lithuania. Now Eddy Travels HQ is in Toronto, Canada with an R&D office in Vilnius, Lithuania.

Practica Capital is a dedicated Baltic venture capital investment firm focusing on investments in the Baltic and Baltic-origin ventures in Europe. The firm invests in seed, late seed and Series A ventures backing great teams behind the tech-driven businesses from the region since 2011.

Open Circe Capital is a venture fund management company focusing on early-stage Lithuanian start-ups in Deep-Tech, ICT and robotics technologies.

Techstars Toronto is part of Techstars accelerator network, which provides 3-month startup accelerator programs around the world, up to $120,000 in funding, and mentorship. Techstars Toronto is supported by Real Ventures.

Let’s block ads! (Why?)

Miscw.com

Recent Posts

Zhengzhou: Interactive Exhibitions on the International Museum Day

ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…

6 hours ago

Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally

Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…

16 hours ago

Quality Building Award 2024 Unveils Finalist List

QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…

2 days ago

UXLINK Tops RootData’s Latest X Hot Items List and DappRadar Social Apps List

SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…

2 days ago

Australia Construction Industry Report 2024: Growth to Slow to 2% in Real-terms this Year Following 9% Growth in 2023 – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…

2 days ago

Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast

Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…

2 days ago